[ad_1]
Bulgaria will apply at least two types of preparations
There is no official plan yet, but leading doctors are working out scenarios
Vaccination against COVID-19 in Bulgaria will start in mid-February.
The main question in the European Union is which vaccine will be approved first and what type will it be.
Certainly, Bulgaria will not use only one of the products, but vaccines of both types will be administered in parallel: vector from Astra Zeneca or with messenger RNA, such as Bayontek and Pfizer
The second type of problem is logistics: special freezers are required for storage. Therefore, vaccination with them will be carried out by large hospitals that have or may be equipped with such freezers. Probably the first stage for the immunization of risk professions will take place there: for doctors, teachers, policemen, etc.
Mass immunization of groups at risk (homes for the elderly and chronically ill) is likely to be done with the vector-type vaccine.
Vaccination is a more basic medical procedure than taking material for a PCR test. But anyway
general practicesThe chefs
doctors they will be
included actively
in this immunization. For now, it is mainly in the direction of large hospitals to immunize their staff to stop the epidemic among doctors, nurses and paramedics.
RNA-type vaccines have no theoretical side effects, so they use artificially created messenger RNA, which is not a weakened virus.
The other, the so-called Oxford vaccine, which is of the vector type, will be offered by Astra Zeneca. It has successfully passed the super stringent triple safety tests of the European Medicines Agency before its efficacy was evaluated. Behind this lies a great experience and knowledge in the field of vaccines.
In fact, this vaccine was developed in record time thanks to this experience.
But due to safety testing, it was outmatched by Russia’s Sputnik V, which is similar to the Astra Zeneca.
Oxford has proven to be safe, especially
applications as base
existing
vaccines against
other dangerous
virus,
which have been shown to be harmless in practice.
The Bayontek and Pfizer vaccine has been developed using new technology.
Doctors hope the infection will break down in response to restrictions now and a vaccination campaign in February targeting high-risk occupations.
Epidemiologists believe that the current wave is due to the massive neglect of measures in early October due to good weather, when there were large concentrations of people with symptoms.
If the restrictions are observed now, with a natural cycle of 3 weeks of the virus by Christmas, the cases will start to decline naturally. If the population persists for at least another 3 weeks not to meet with patients much and without vaccines, the cases will decrease.
In England, people with a COVID passport will travel more easily
PAVLINA TRIFONOVA
Regulators in the UK may already this week allow the use of the Pfizer and Bayontek coronavirus vaccine and make the country the first in the world to implement it.
The British NHS has been instructed to make the necessary arrangements for vaccination and a special schedule has been announced. 40 million doses have been ordered, of which 10 million will be delivered by the end of 2020. They will reach 5 million people.
Those who live in nursing homes and care for them will be the first to receive the vaccine. Then front-line doctors and people over the age of 85. The UK plans to vaccinate all citizens for free, requesting the highest number of doses from the University of Oxford – 100 million units. The process is estimated to take 2 years.
To encourage people to get vaccinated, the British authorities are discussing the introduction of a “COVID passport”. It is a certificate that will allow vaccinated people to travel more easily and not isolate themselves after contact with an infected person.
London is trying to reduce the 14-day quarantine for overseas contacts and travelers by replacing it with rapid tests. They will take place every day of the week and if they are negative, people will return to normal life.
[ad_2]
